The A9 Antigen Associated with Aggressive Human Squamous Carcinoma Is Structurally and Functionally Similar to the Newly Defined Integrin α6β4l

Cancer Research

Volumn 51, Issue 9, 1991, Pages 2395-2402

  Carey, Thomas E ^a,e   Warren, Amy B ^a   Kidd, Lisa ^a   Paugh, Donald ^a  

^a Cancer Research Laboratory   (United States)

^b Section of Rheumatology   (United States)

^c Department of Surgeiy ^*  (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e Experimental Breast Cancer Research Laboratory University of Michigan North Campus Research Complex   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ARTICLE; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; GLYCOSYLATION; HUMAN; INTEGRIN ALPHA6BETA4; INTEGRINS; PEPTIDE MAPPING; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR MARKERS, BIOLOGICAL;

EID: 0025911170     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Liotta, L. A., Rao, C. N., and Wewer, U. M. Biochemical interactions of tumor cells with the basement membrane. Annu. Rev. Biochem., 55: 10371057, 1986.
2. Wagner, D. D., Ivatt, R., Destree, A. T., and Hynes, R. O. Similarities and differences between the fibronectins of normal and transformed hamster cells. J. Biol. Chem., 256: 11708-11715,1981.
3. Castellani, P., Siri, A., Rosellini, C., Infusini, E., Borsi, L., and Zardi, L. Transformed human cells release different flbronectin variants than do normal cells. J. Cell Biol., 103:1671-1677, 1986.
4. Schwarzbaner, J. E., Patel, R. S., Fonda, D., and Hynes, R. O. Multiple sites of alternative splicing of the rat flbronectin gene transcript. EM BO J., 6: 2573-2580,1987.
5. Frenette, G. P., Carey, T. E., Varani, J., Schwartz, D. R., Fligiel, S. E. G., Ruddon, R. W., and Peters, B. P. Biosynthesis and secretion of laminin and laminin-associated glycoproteins by nonmalignant and malignant human keratinocytes: comparison of cell lines from primary and secondary tumors in the same patient. Cancer Res., 48:5193-5202, 1988.
6. Plantefaber, L. C., and Hynes, R. O. Changes in integrin receptors on oncogenically transformed cells. Cell, 56: 281-290, 1989.
7. Krief, P., Saint-Ruf, C., Bracke, M., Boucheix, C., Billard, C., Billard, M., Cassingena, R., Jasmin, C., Mareel, M., and Azzarone, B. Acquisition of tumorigenic potential in the human myoepithelial HBL100 cell line is associated with decreased expression of the HLA class I, class II, and integrin 03 and increased expression of c-myc. Int. J. Cancer, 43:658-664,1989.
8. Oz, O., Campbell, A., and Tao, T-W. Reduced cell adhesion to flbronectin and laminin is associated with altered glycosylation of 0i integrins in a weakly metastatic glycosylation mutant. Int. J. Cancer, 44:343-347, 1989.
9. Wewer, U. M., Liotta, L. A., Jaye, M., Ricca, G. A., Drohan, W. N., Claysmith, A. P., Rao, C. N., Wirth, P., Coligan, J. E., Albrechtsen, R., Mudryj, M., and Sobel, M. E. Altered levels of laminin receptor mRNA in various human carcinoma cells that have different abilities to bind laminin. Proc. Natl. Acad. Sci. USA, 83:7137-7141, 1986.
10. Yow, H., Wong, J. M., Chen, H. S., Lee, C., Steele, G. D., Jr., and Chen, L. B. Increased mRNA expression of a laminin-binding protein in human colon carcinoma: complete sequence of a full-length cDNA encoding the protein. Proc. Natl. Acad. Sci. USA, 85:6394-6398, 1988.
11. McGregor, B. C., McGregor, J. L., Weiss, L. M., Wood, G. S., Hu, C H., Boukerche, H., and Wamke, R. A. Presence of cytoadhesins (Ilb-IIla-like glycoproteins) on human metastatic melanomas but not on benign melanocytes. Am. J. Clin. Pathol., 92:4956-4999, 1989.
12. Kimmel, K. A., and Carey, T. E. Altered expression in squamous carcinoma cells of an orientation restricted epithelial antigen detected by monoclonal antibody A9. Cancer Res., 46:3614-3623, 1986.
13. Carey, T. E., Wolf, G. T., Hsu, S., Poore, J., Peterson, K., and McClatchey, K. D. Expression of A9 antigen and loss of blood group antigens as determinants of survival in patients with head and neck squamous carcinoma. Otolaryngol. Head Neck Surg., 96: 221-230,1987.
14. Wolf, G. T., Carey, T. E., Schmaltz, S. P., McClatchey, K. D., Poore, J., Glaser, L., Hayashida, D. J. S., and Hsu, S. Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck. J. Natl. Cancer Inst., 82: 1566-1572, 1990.
15. Hemler, M. E., Crouse, C., and Sonnenberg, A. Association of the VLA a6 subunit with a novel protein. A possible alternative to the common VLA 0, subunit on certain cell lines. J. Biol. Chem., 264:6529-6539, 1989.
16. Kajiji, S., Tamura, R. N., and Quaranta, V. A novel integrin (aE/34) from human epithelial cells suggests a fourth family of integrin adhesion receptors. EMBO J., 8:673-680, 1989.
17. Kennel, S. J., Foote, L. J., Falcioni, R., Sonnenberg, A., Stringer, C. D., Crouse, C., and Hemler, M. E. Analysis of the tumor-associated antigen TSP-180. Identity with a604 in the integrin superfamily. J. Biol. Chem., 264: 15515-15521, 1989.
18. Sonnenberg, A., Modderman, P. W., and Hogervorst, F. Laminin receptor on platelets is the integrin VLA-6. Nature (Lond.), 336:487-489, 1988.
19. Hemler, M. E., Ware, C. F., and Strominger, J. L. Characterization of a novel differentiation antigen complex recognized by a monoclonal antibody (A1A5): unique activation-specific molecular forms on stimulated T cells. J. Immunol., 131:334-340, 1983.
20. Lotz, M. M., Korzelius, C. A., and Mercurio, A. M. Human colon carcinoma cells use multiple receptors to adhere to laminin: involvement of a6/34 and 20, integrins. Cell Regul., /:249-257, 1990.
21. Falcioni, R., Sacchi, A., Resau, J., and Kennel, S. J. Monoclonal antibody to human carcinoma-associated protein complex: quantitation in normal and tumor tissue. Cancer Res., 48:816-821, 1988.
22. Werb, Z., Tremble, P. M., Behrendtsen, O., Crowley, E., and Damsky, C. H. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J. Cell Biol., 109: 877-889.
23. Kaminski, M. S., Kitamura, K., Maloney, D. G., Campbell, M. J., and Levy, R. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants. J. Immunol., 136: 1123-1130,1986.
24. Dialynas, D., Loken, M., Sarmiento, M., and Fitch, F. W. Identification of lysis-relevant molecules on the surface of CTL: primary screening of monoclonal antibodies for the capacity to block cytolysis by cloned CTL lines. In: W. R. Clark and P. Golstein (eds.), Advances in Experimental Medicine and Biology, Vol. 146, pp. 547-556. New York: Plenum Publishing Corporation, 1982.
25. Zajic, G., Nair, T. S., Ptok, M., Van Waes, C., Altschuler, R. A., Schacht, J., and Carey, T. E. Monoclonal antibodies to inner ear antigens: I. Antigens expressed by supporting cells in guinea pig cochlea. Hear. Res., in press, 1991.
26. Krause, C. J., Carey, T. E., Ott, R. W., Hurbis, C., McClatchey, K. D., and Regezi, J. A. Human squamous cell carcinoma. Establishment and characterization of new permanent cell lines. Arch. Otolaryngol., 107: 703-710, 1981.
27. Carey, T. E., Wolf, G. T., Baker, S. R., and Krause, C. J. Cell surface antigen expression and prognosis. In: W. E. Fee, Jr., H. Goepfert, M. E. Johns, E. W. Strong, and P. H. Ward (eds.), Head and Neck Cancer, Vol. 2, pp. 7782. Toronto: B. C. Decker, Inc., 1990.
28. Van Waes, C., Urban, J. L., Rothstein, J. L., Ward, P. L., and Schreiber, H. Highly malignant tumor variants retain tumor-specific antigens recognized by T helper cells. J. Exp. Med., 164: 1547-1565, 1986.
29. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 277:680-685,1970.
30. O'Farrell, P. H. High resolution two-dimensional electrophoresis of proteins. J. Biol. ChemM 250:4007-4021,1975.
31. Cleveland, D. W., Fischer, S. G., Kirschner, M. W., and Laemmli, U. K. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J. Biol. Chem., 252:1102-1106,1977.
32. Ruoslahti, E., Hayman, E. G., Piersbacher, M., and Engvall, E. Fibronectin: purification, immunochemical properties and biological activities. Methods Enzymol., 82:803-831,1982.
33. Languino, L. R., Gehlsen, K. R., Wayner, E., Carter, W. G., Engvall, E., and Ruoslahti, E., Endothelial cells use a2/Si integrin as a laminin receptor. J. Cell Biol., 109:2455-2462,1989.
34. Falcioni, R., Kennel, S. J., Giacomini, P., Zupi, G., and Sacchi, A. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice. Cancer Res., 46:5772-5778,1986.
35. Sonnenberg, A., Janssen, H., Hogervorst, F., Calafat, J., and Hilgers, J. A complex of platelet glycoproteins 1c and Ila identified by a rat monoclonal antibody. J. Biol. Chem., 262:10376-10383,1987.
36. Sonnenberg, A., Daams, H., Van Der Valk, M. A., Hilkens, J., and Hilgers, J. Development of mouse mammary gland: identification of stages in differentiation of luminal and myoepithelial cells using monoclonal antibodies and polyvalent antiserum against keratin. J. Histochem. Cytochem., 34: 10371046,1986.
37. Pischel, K. D., Hemler, M. E., Huang, C., Bluestein, H. G., and Woods, V. L., Jr. Use of the monoclonal antibody 12F1 to characterize the differentiation antigen VLA-2. J. Immunol., 138:226-233, 1987.
38. Fradet, Y., Cordon-Cardo, C., Thomson, T., Daly, M. E., Whitmore, W. F., Jr., Lloyd, K. O., Melamed, M. R., and Old, L. J. Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proc. Natl. Acad. Sci. USA, 81: 224-228,1984.
39. Sonnenberg, A., Hogervorst, F., Osterop, A., and Veltman, F. E. M. Identification and characterization of a novel antigen complex on mouse mammary tumor cells using a monoclonal antibody against platelet glycoprotein Ic. J. Biol. Chem., 263:14030-14038,1988.
40. Hsi-B-L., Yeh, C-J., Samson, M., and Fehlman, M. Monoclonal antibody GB36 raised against human trophoblast recognizes a novel epithelial antigen. Placenta, 8:209-217,1987.
41. Hogervorst, F., Kuikman, I., von dem Born, A. E. G. K., and Sonneberg, A. Cloning and sequence analysis of beta-4 cDNA: an integrin subunit that contains a unique 118 kD cytoplasmic domain. EMBO J., 9:765-770,1990.
42. Varani, J., Carey, T. E., Fligiel, S. E. G., McKeever, P. E., and Dixit, V. Tumor type-specific differences in cell-substrate adhesion among human tumor cell lines. Int. J. Cancer, 39:397-403,1987.
43. Wewer, U. M., Taraboletti, G., Sobel, M. E., Albrechtsen, R., and Liotta, L. A. Role of laminin receptor in tumor cell migration. Cancer Res., 47:56915698, 1987.
44. Liotta, L. A., Rao, C. N., and Barsky, S. H. Laminin receptors in human breast carcinoma: role in invasion of the extracellular matrix. In: M. A. Rich, J. C. Hager, and P. Furmanski (eds.), Understanding Breast Cancer Clinical and Laboratory Concepts, pp. 87-97. New York: Marcel Dekker, Inc., 1983.
45. Gianotti, F. G., Comoglio, P. M., and Tarone, G. A 135,000 molecular weight plasma membrane glycoprotein involved in fibronectin-mediated cell adhesion. Exp. Cell Res., 163:47-62,1986.
46. Chen, W-T., Wang, J., Hasegawa, T., Yamada, S., and Yamada, K. Regulation of fibronectin receptor distribution by transformation, exogenous fibronectin, and synthetic peptides. J. Cell Biol., 103:1649-1661,1986.
47. Horwitz, A., Duggan, K., Buck, C., Beckerle, M. C., and Burridge, K. Interaction of plasma membrane fibronectin receptor with talin a transmembrane linkage. Nature (Lond.), 320:531-533,1986.
48. Argraves, W. S., Dickerson, K., Burgess, W. H., and Ruoslahti, E. Fibulin, a novel protein that interacts with the fibronectin receptor 0 subunit cytoplasmic domain. Cell, 58:623-629,1989.
49. Ramos, D. M., Berston, E. D., and Kramer, R. H. Analysis of integrin receptors for laminin and type IV collagen on metastatic B16 melanoma cells. Cancer Res., 50:728-734,1990.
50. Sonnenberg, A., Linders, C. J. T., Modderman, P. W., Damsky, C. H., Aumailley, M., and Timpl, R. Integrin recognition of different cell-binding fragments of laminin (PI, E3, E8) and evidence that a601 but not a604 functions as a major receptor for fragment E8. J. Cell Biol., 110:2145-2155, 1990.